Skip to content

Methylprednisolone for primary intracerebral hemorrhage: a randomized double-blind, placebo-controlled trial

Methylprednisolone for primary intracerebral hemorrhage: a randomized double-blind, placebo-controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10001141
Enrollment
Unknown
Registered
2010-12-25
Start date
2011-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute primary supratentorial intracerebral hemorrhage

Interventions

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age from 18 to 80 years; 2. Acute spontaneous supratentorial ICH; 3. Haematoma volume between 10 to 30ml; 4. GCS score>8; 5. Admission within 24 hours of ictus.

Exclusion criteria

Exclusion criteria: 1. The haemorrhage was probably due to an aneurysm or an angiographically proven intracranial vascular malformation or tumour stroke; 2. Associated with head injury or traumatic history; 3. Patients with mutiple intracerebral hemorrhage; 4. Patients who had severe pre-existing physical and/or mental disability; 5. Coagulation disorders or history of anticoagulant; 6. History of gastric ulcer or diabetes mellitus ; 7. Hypoimmunity or infection; 8. Patients who have reveived long-term glucocorticord treatment; 9. Patients who received drugs which may influnce blood sugar, immunity, gastrointestinal function or the methylprednisolone metabolism 1month prior to the enrollment; 10. Hepatic and/or renal dysfunction.

Design outcomes

Primary

MeasureTime frame
Edema aroud the hematoma, Mortality, GOS score, Modified Rankin Scale, NIHSS Scale;

Secondary

MeasureTime frame
Hepatic and renal function, electrolyte, size of hematoma, vital indications;

Countries

China

Contacts

Public ContactChao You, Ming Liu
youchao@mail.sc.cninfo.net+86 13908036660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026